Grand duchy

EQS-News: hep solar projects GmbH: 8% Green Bond 2023/2028 with a volume of EUR 16.8 million tradable on “Freiverkehr” of Frankfurt Stock Exchange

Retrieved on: 
Wednesday, April 10, 2024

This publication is neither an offer to sell nor a solicitation of an offer to buy securities.

Key Points: 
  • This publication is neither an offer to sell nor a solicitation of an offer to buy securities.
  • Outside the Federal Republic of Germany, the Grand Duchy of Luxembourg and the Republic of Austria, no public offer is being made.
  • These statements are based on the current views, expectations, assumptions and information of the management of hep solar projects GmbH.
  • Forward-looking statements should not be construed as a promise of future results and developments and involve known and unknown risks and uncertainties.

NeoGames Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, March 6, 2024

LUXEMBOURG, March 06, 2024 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery and iGaming solutions, announced today financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • iLottery revenues were $14.4 million during the fourth quarter of 2023, compared to $14.5 million during the fourth quarter of 2022, representing a decrease of (0.4)% year-over-year.
  • In addition, the Company’s share in NPI revenues was $17.2 million during the fourth quarter of 2023, compared to $14.0 million during the fourth quarter of 2022, representing an increase of 22.9% year-over-year.
  • Adjusted net income1 was $1.7 million, or $0.05 per share, during the fourth quarter of 2023, compared to $7.3 million, or $0.22 per share, during the fourth quarter of 2022.
  • Adjusted EBITDA¹ was $18.2 million during the fourth quarter of 2023, compared to $18.1 million during the fourth quarter of 2022, representing an increase of 0.4% year-over-year.

Luxembourg and Pony.ai Sign MoU to Advance Autonomous Mobility in the Country

Retrieved on: 
Thursday, March 7, 2024

Pony.ai, a leading global autonomous mobility company, held a Memorandum of Understanding (MoU) signing ceremony today with the Government of the Grand Duchy of Luxembourg (“The Government”) to advance the development of autonomous mobility in Luxembourg.

Key Points: 
  • Pony.ai, a leading global autonomous mobility company, held a Memorandum of Understanding (MoU) signing ceremony today with the Government of the Grand Duchy of Luxembourg (“The Government”) to advance the development of autonomous mobility in Luxembourg.
  • The MoU was signed by Pony.ai Co-Founder and CEO Dr. James Peng and Luxembourg’s Minister of the Economy Lex Delles.
  • This MoU represents a collaborative partnership between Luxembourg and Pony.ai, with the objective of fostering the research, development, and deployment of autonomous vehicles in Luxembourg.
  • As such, I am very pleased with the signature of an MoU with Pony.ai, a leader in autonomous mobility technologies and services.

NSPA awards COMLOG a contract for Patriot missiles

Retrieved on: 
Wednesday, January 3, 2024

GEM-T, the Patriot Advanced Capability 2 (PAC-2) missile interceptor enhanced for defeating tactical ballistic missiles, is a primary effector for the combat-proven Patriot air and missile defense system.

Key Points: 
  • GEM-T, the Patriot Advanced Capability 2 (PAC-2) missile interceptor enhanced for defeating tactical ballistic missiles, is a primary effector for the combat-proven Patriot air and missile defense system.
  • The world's battle-proven air and missile defense system, Patriot is relied upon by eight European nations, and Ukraine, for defense against cruise missiles, ballistic missiles, and enemy drones and aircraft.
  • The new production capacity for Patriot GEM-T missiles in Europe enhances security of supply and will contribute to the replenishment of Patriot air defense missile inventories.
  • COMLOG's main customer is the NSPA, which operates on behalf of the European Patriot user countries and the U.S. Army.

NeoGames Announces Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 8, 2023

LUXEMBOURG, Nov. 08, 2023 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the "Company"), a technology-driven provider of end-to-end iLottery and iGaming solutions, announced today financial results for the third quarter ended September 30, 2023. 

Key Points: 
  • – Third Quarter Net Loss of $3.6 million and Adjusted Net Income, after taking effect of the amortization of Aspire intangibles, was $4.4 million –
    – Third Quarter Adjusted EBITDA total $19.9 million, an increase of 13% year-over-year –
    LUXEMBOURG, Nov. 08, 2023 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the "Company"), a technology-driven provider of end-to-end iLottery and iGaming solutions, announced today financial results for the third quarter ended September 30, 2023.
  • iLottery revenues were $14.4 million during the third quarter of 2023, compared to $13.7 million during the third quarter of 2022, representing an increase of 5.6% year-over-year.
  • Adjusted EBITDA1 was $19.9 million during the third quarter of 2023, compared to $17.6 million during the third quarter of 2022, representing an increase of 12.9% year-over-year.
  • In light of the expected sale of the Company to Aristocrat, NeoGames will not be hosting a conference call, or providing quantitative financial guidance in conjunction with its third quarter 2023 earnings release.

Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea

Retrieved on: 
Wednesday, November 1, 2023

These positive preliminary findings offer hope for patients with this condition, particularly in the face of rising antibiotic resistance to current regimens.

Key Points: 
  • These positive preliminary findings offer hope for patients with this condition, particularly in the face of rising antibiotic resistance to current regimens.
  • It also paves the way for a new research and development model in the global fight against antimicrobial resistance (AMR).
  • Now, the positive results of this landmark Phase 3 trial confirm that zoliflodacin has the potential to tackle the most difficult-to-treat gonorrhea infections.
  • This builds on the critical Phase 2 clinical trial sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID).

EQS-News: hep solar projects GmbH issues 8% Green Bond 2023/2028 with a volume of up to EUR 30 million

Retrieved on: 
Tuesday, October 17, 2023

This publication is neither an offer to sell nor a solicitation of an offer to buy securities.

Key Points: 
  • This publication is neither an offer to sell nor a solicitation of an offer to buy securities.
  • Outside the Federal Republic of Germany, the Grand Duchy of Luxembourg and the Republic of Austria, no public offer is being made.
  • These statements are based on the current views, expectations, assumptions and information of the management of hep solar projects GmbH.
  • Forward-looking statements should not be construed as a promise of future results and developments and involve known and unknown risks and uncertainties.

EQS-News: Marcel Lux III SARL: Announcement of the fulfillment of the Offer Condition; settlement of the Offer

Retrieved on: 
Wednesday, October 4, 2023

Marcel Lux III SARL: Announcement of the fulfillment of the Offer Condition; settlement of the Offer

Key Points: 
  • Marcel Lux III SARL: Announcement of the fulfillment of the Offer Condition; settlement of the Offer
    The issuer is solely responsible for the content of this announcement.
  • Unless defined elsewhere herein, capitalised terms used below have the meaning given to them in the Offer Document.
  • Pursuant to Section 11.1 of the Offer Document, the Offer and the agreements that have been entered into as a result of its acceptance by the SUSE Shareholders are subject to the Offer Condition.
  • The Offer itself as well as its definite terms and conditions and further provisions concerning the Offer are published in the Offer Document.

EQS-News: Marcel Lux III SARL: Publication of the final acceptances of the of the voluntary public purchase offer by Marcel LUX III SARL for the acquisition of shares in SUSE S.A.

Retrieved on: 
Wednesday, September 27, 2023

Marcel Lux III SARL: Publication of the final acceptances of the of the voluntary public purchase offer by Marcel LUX III SARL for the acquisition of shares in SUSE S.A.

Key Points: 
  • Marcel Lux III SARL: Publication of the final acceptances of the of the voluntary public purchase offer by Marcel LUX III SARL for the acquisition of shares in SUSE S.A.
  • above, amounts to 167,908,304 SUSE Shares; this corresponds to approximately 98.2% of the share capital and the voting rights in SUSE.
  • This publication is neither an offer to purchase nor a solicitation of an offer to sell shares in SUSE or any other securities.
  • The Offer itself as well as its definite terms and conditions and further provisions concerning the Offer are published in the Offer Document.

EQS-News: Marcel Lux III SARL: Notification of Publication of Offer Document

Retrieved on: 
Thursday, August 24, 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN OR INTO ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

Key Points: 
  • NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN OR INTO ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
  • This publication is neither an offer to purchase nor a solicitation of an offer to sell shares in SUSE or any other securities.
  • The Offer itself as well as its definite terms and conditions and further provisions concerning the Offer are published in the Offer Document.
  • Investors and SUSE Shareholders are strongly advised to thoroughly read the entire Offer Document and all other relevant documents regarding the Offer when they become available, as they will contain important information.